As the understanding of secondary immunodeficiency (SID) continues to evolve, collaboration among healthcare professionals, researchers, regulators, patient advocates, and industry stakeholders has never been more important.
On Friday, August 7, from 9:00–10:30 a.m. ET, the Plasma Protein Therapeutics Association (PPTA) will host Beyond Labels: Ensuring Access to IG Therapy for Secondary Immunodeficiency, a virtual educational webinar examining the latest perspectives on immunoglobulin (IG) therapy and patient-centered care.
A Multidisciplinary Discussion
Patients living with secondary immunodeficiency—particularly those with secondary hypogammaglobulinemia, an acquired antibody deficiency characterized by low immunoglobulin levels—may face an increased risk of serious infections and other complications. As clinical evidence continues to develop, ongoing dialogue is essential to helping stakeholders better understand evolving treatment considerations and opportunities to improve patient care.
This webinar will bring together experts representing patient advocacy, clinical practice, scientific research, and regulatory policy to explore the current landscape from multiple perspectives.
Participants will hear discussions on:
- The patient experience of living with secondary immunodeficiency
- Emerging clinical evidence surrounding IG therapy
- Regulatory considerations, including the European Medicines Agency's perspective
- Patient-centered approaches to supporting informed care decisions
REGISTER TODAY
Learn from Leading Experts
The webinar features an accomplished panel of speakers, including:
- Dr. James Knowles, Vice President, Global Regulatory Policy & Scientific Affairs, PPTA
- Caroline Voltz-Girolt, Scientific Lead, Oncology and Hematology Office, European Medicines Agency (EMA)
- Charlene Grabowski, Patient and Board Member, Immune Deficiency Foundation (IDF)
- Dr. Stephan Grupp, Section Chief, Cellular Therapy and Transplant, Children's Hospital of Philadelphia (CHOP)
Together, these experts will share insights into the evolving scientific, clinical, regulatory, and patient perspectives surrounding IG therapy and secondary immunodeficiency.
Whether you are a healthcare professional, researcher, regulator, patient advocate, or work within the plasma community, this webinar offers an opportunity to hear from leading experts and engage in an important discussion about advancing patient-centered care.
Join us on Friday, August 7, from 9:00–10:30 a.m. ET. Register today to reserve your place and be part of the conversation.